Graf Akcie ASND (Ascendis Pharma A/S). Diskuze k akciím ASND. Aktuální informace ASND.

Základní informace o společnosti Ascendis Pharma A/S (Akcie ASND)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 9.13B
Hodnota podniku (EV) N/A
Tržby 0
EBITDA N/A
Zisk -€457.87
Růst v tržbách Q/Q -28.83 %
Růst v tržbách Y/Y -39.84 %
P/E (Cena vůči ziskům) 0.00
Forward P/E N/A
EV/Sales 1,779.76
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 1,562.12
P/FCF N/A
Price/Book 9.42
Účetní hodnota na akcii 16.98
Hotovost na akcii 14.55
FCF vůči ceně -4.60 %
Počet zaměstnanců 2,020
Tržba na zaměstnance €2.505k
Profit margin -6,025.53 %
Operating margin -8,236.11 %
Gross margin 100.00 %
EBIT margin -8,236.11 %
EBITDA margin -2,759.32 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 26.61 %
EPS - Očekávaný růst příští rok -4.27 %
Return on assets -47.66 %
Return on equity -55.83 %
ROIC -39.90 %
ROCE -53.32 %
Dluhy/Equity 0.17
Čistý dluh/EBITDA N/A
Current ratio 8.31
Quick Ratio 8.00
Volatilita 3.97
Beta 0.33
RSI 50.42
Cílová cena analytiků 187
Známka akcie (dle analytiků) 1.00
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 56.401M
Procento shortovaných akcií 0.00 %
Short ratio 13.58 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2015
Země Denmark

Finanční výsledky akcie ASND

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$14.98$12.496$1.729$5.097$9.014$18.588-
Cost Of Goods Sold-------
Gross Profit$14.98$12.496$1.729$5.097$9.014$18.588-
Research And Development Expenses$214.616$165.672$112.565$73.06$45.002$26.185-
SG&A Expenses$54.29$29.592$15.239$12.73$10.454$8.34-
Other Operating Income Or Expenses-------
Operating Expenses$268.905$195.264$127.804$85.79$55.457$34.525-
Operating Income$-253.925$-182.768$-126.075$-80.693$-46.443$-15.937-
Total Non-Operating Income/Expense$9.485$28.658$-14.505$4.634$9.162$2.192-
Pre-Tax Income$-244.44$-154.11$-140.58$-76.059$-37.281$-13.745-
Income Taxes$-0.262$-0.465$-0.539$-0.251$-0.724$-0.907-
Income After Taxes$-244.178$-153.645$-140.041$-75.808$-36.557$-12.838-
Other Income-------
Income From Continuous Operations$-244.178$-153.645$-140.041$-75.808$-36.557$-12.838-
Income From Discontinued Operations-------
Net Income$-244.178$-153.645$-140.041$-75.808$-36.557$-12.838-
EBITDA$-246.434$-181.729$-125.245$-79.944$-45.823$-15.267-
EBIT$-253.925$-182.768$-126.075$-80.693$-46.443$-15.937-
Basic Shares Outstanding4741342724--
Shares Outstanding4741342724--
Basic EPS$-5.25$-3.74$-4.16$-2.85$-1.54--
EPS - Earnings Per Share$-5.25$-3.74$-4.16$-2.85$-1.54--
# 2020 2019 2018 2017 2016 2015
Current Ratio12.73537.52638.609613.66910.97894.1336
Long-term Debt / Capital------
Debt/Equity Ratio------
Gross Margin100100100100100100
Operating Margin-1695.095-1462.593-7290.261-1583.152-515.2131-85.7398
EBIT Margin-1695.095-1462.593-7290.261-1583.152-515.2131-85.7398
EBITDA Margin-1645.084-1454.277-7242.288-1568.454-508.3395-82.1354
Pre-Tax Profit Margin-1631.776-1233.258-8129.019-1492.227-413.5748-73.9469
Net Profit Margin-1630.026-1229.534-8097.842-1487.299-405.5432-69.0696
Asset Turnover0.01980.03320.00730.02420.06160.2383
Inventory Turnover Ratio------
Receiveable Turnover2.47094.02320.64392.7633.71365.8876
Days Sales In Receivables147.719390.7239566.8235132.100598.286561.9949
ROE - Return On Equity-36.5116-46.4549-66.1804-38.7882-27.36-21.0827
Return On Tangible Equity-36.7266-47.042-67.4394-39.5713-28.1784-22.8241
ROA - Return On Assets-32.216-40.7869-58.7248-36.0418-24.9837-16.4613
ROI - Return On Investment-36.5116-46.4549-66.1804-38.7882-27.36-21.0827
Book Value Per Share13.93677.84955.72716.02825.31733.5956
Operating Cash Flow Per Share-0.2471-0.7933-0.6897-0.4761-2.0308-
Free Cash Flow Per Share-0.2952-0.8378-0.6933-0.4556-2.0793-